EHRA Premium Access

Efficacy and safety of 50-60 Watt high-power short-duration radiofrequency catheter ablation of atrial fibrillation: A propensity score matching study

Topic: Rhythm Control, Catheter Ablation


About the speaker

Doctor Je Wook Park

Yonsei University Health system, Seoul (Korea (Republic of))
0 follower

5 more presentations in this session

Impact of initial rhythm control with cryoballoon ablation versus drug therapy on atrial fibrillation recurrence and quality of life: results from the Cryo-FIRST study

Speaker: Doctor N. Pavlovic (Zagreb, HR)


Early rhythm-control ablation therapy in preventing AF recurrences: insight from the CHARISMA Registry

Speaker: Doctor L. Segreti (Pisa, IT)


Prognosis of new-onset of atrial fibrillation in acute coronary syndrome: Portuguese experience

Speaker: Doctor H. Santos (Barreiro, PT)


Endocardial left atrial appendage occlusion in atrial fibrillation: computational fluid dynamics simulations to assess stroke risk

Speaker: Associate Professor C. Corsi (Bologna, IT)


Left atrial strain imaging evaluation: a strong predictor of atrial fibrillation recurrence after single-procedure catheter ablation

Speaker: Doctor P. Garcia Bras (Lisbon, PT)


Access the full session

Treatment and prognosis of atrial fibrillation

Speakers: Doctor J. Park, Doctor N. Pavlovic, Doctor L. Segreti, Doctor H. Santos, Associate Professor C. Corsi...

About the event


EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Related content

Open Access

Anticoagulation/avoid stroke in patients with valvular heart disease.

28 August 2021

Open Access

New recommendations for the treatment of HFrEF.

27 August 2021

ESC Premium Access

Syncope as the initial manifestation of advanced nasopharyngeal carcinoma: a case report.

27 August 2021

This platform is supported by

logo Novo Nordisk